ARTICLE SUMMARY:
The Trump administration has rolled out two proposed regulations intended to modernize kickback and self-referral protections for the value-based era, but there are still questions to be answered about exactly where device companies fit in.
Medtech firms were hoping for more legal assurances to support setting up value-based, risk-sharing contracts with hospitals and others in two proposed rules dropped by the Trump administration October 9.
